| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |